Cadila Healthcare Limited Stock NSE India S.E.
Equities
INE010B01019
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
Sales 2024 | 195B 2.35B 3.2B | Sales 2025 * | 213B 2.55B 3.47B | Capitalization | 1,058B 12.71B 17.3B |
---|---|---|---|---|---|
Net income 2024 | 38.6B 464M 631M | Net income 2025 * | 43.25B 519M 707M | EV / Sales 2024 | 5.19 x |
Net cash position 2024 * | 13.47B 162M 220M | Net cash position 2025 * | 33.33B 400M 545M | EV / Sales 2025 * | 4.82 x |
P/E ratio 2024 |
26.4
x | P/E ratio 2025 * |
25.8
x | Employees | - |
Yield 2024 * |
0.55% | Yield 2025 * |
0.55% | Free-Float | 24.87% |
Latest transcript on Cadila Healthcare Limited
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | 97-07-31 | |
Director of Finance/CFO | - | - | |
Chairman | 71 | 95-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 18-12-05 | |
Chairman | 71 | 95-05-14 | |
Director/Board Member | 69 | 97-07-31 |
1st Jan change | Capi. | |
---|---|---|
+21.63% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.56B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B | |
+6.11% | 4.77B |